1. Home
  2. RAPT vs YGMZ Comparison

RAPT vs YGMZ Comparison

Compare RAPT & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • YGMZ
  • Stock Information
  • Founded
  • RAPT 2015
  • YGMZ 2002
  • Country
  • RAPT United States
  • YGMZ China
  • Employees
  • RAPT N/A
  • YGMZ N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • RAPT Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • RAPT Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • RAPT 117.5M
  • YGMZ 101.2M
  • IPO Year
  • RAPT 2019
  • YGMZ 2020
  • Fundamental
  • Price
  • RAPT $0.89
  • YGMZ $1.33
  • Analyst Decision
  • RAPT Buy
  • YGMZ
  • Analyst Count
  • RAPT 5
  • YGMZ 0
  • Target Price
  • RAPT $5.25
  • YGMZ N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • YGMZ 19.3K
  • Earning Date
  • RAPT 05-08-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • YGMZ N/A
  • EPS Growth
  • RAPT N/A
  • YGMZ N/A
  • EPS
  • RAPT N/A
  • YGMZ N/A
  • Revenue
  • RAPT N/A
  • YGMZ $40,429,750.00
  • Revenue This Year
  • RAPT N/A
  • YGMZ N/A
  • Revenue Next Year
  • RAPT N/A
  • YGMZ N/A
  • P/E Ratio
  • RAPT N/A
  • YGMZ N/A
  • Revenue Growth
  • RAPT N/A
  • YGMZ N/A
  • 52 Week Low
  • RAPT $0.71
  • YGMZ $0.64
  • 52 Week High
  • RAPT $4.60
  • YGMZ $4.35
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 48.13
  • YGMZ 55.45
  • Support Level
  • RAPT $0.81
  • YGMZ $1.22
  • Resistance Level
  • RAPT $1.27
  • YGMZ $1.44
  • Average True Range (ATR)
  • RAPT 0.14
  • YGMZ 0.09
  • MACD
  • RAPT 0.01
  • YGMZ -0.02
  • Stochastic Oscillator
  • RAPT 31.55
  • YGMZ 34.38

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: